Mangoceuticals (MGRX) Equity Ratio (2023 - 2025)
Mangoceuticals (MGRX) has disclosed Equity Ratio for 3 consecutive years, with 0.94 as the latest value for Q4 2025.
- Quarterly Equity Ratio rose 4.12% to 0.94 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.94 through Dec 2025, up 4.12% year-over-year, with the annual reading at 0.94 for FY2025, 4.12% up from the prior year.
- Equity Ratio hit 0.94 in Q4 2025 for Mangoceuticals, down from 0.95 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.95 in Q3 2025 to a low of 3.18 in Q1 2024.
- Historically, Equity Ratio has averaged 0.56 across 3 years, with a median of 0.92 in 2025.
- Biggest five-year swings in Equity Ratio: plummeted 442.61% in 2024 and later surged 129.28% in 2025.
- Year by year, Equity Ratio stood at 0.74 in 2023, then grew by 23.06% to 0.91 in 2024, then increased by 4.12% to 0.94 in 2025.
- Business Quant data shows Equity Ratio for MGRX at 0.94 in Q4 2025, 0.95 in Q3 2025, and 0.92 in Q2 2025.